Wacth Our News Here
2025 - HAS completes the acquisition of Cerbios-Pharma SA - Riccardo Braglia, Chairman
2025 - Nasce un Nuovo Gruppo Farmaceutico in Ticino - Riccardo Braglia, Chairman - Waldo Mossi, CEO of HAS - Christian Suà, CEO of Cerbio-Pharma
2024 - CPHI MILAN Giacomo Braglia, Marketing & Communication Manager
2024 - New Quality Control Laboratory Center
2023 - CPHI Barcelona, Sandra Moro, Director of Business Development
